BIAF
bioAffinity Technologies, Inc.NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$18.80M
P/E Ratio
—
EPS
$-8.66
Beta
-0.81
52W High
$20.40
52W Low
$0.69
50-Day MA
$1.85
200-Day MA
$4.06
Dividend Yield
—
Profit Margin
-242.00%
Forward P/E
—
PEG Ratio
—
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.
Fundamentals
| Revenue (TTM) | $6.16M |
| Gross Profit (TTM) | $1.94M |
| EBITDA | $-10.07M |
| Operating Margin | -197.00% |
| Return on Equity | -301.80% |
| Return on Assets | -75.60% |
| Revenue/Share (TTM) | $3.58 |
| Book Value | $1.62 |
| Price-to-Book | 2.41 |
| Price-to-Sales (TTM) | 3.05 |
| EV/Revenue | 2.01 |
| EV/EBITDA | -0.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -27.80% |
| Shares Outstanding | $4.50M |
| Float | $4.27M |
| % Insiders | 3.26% |
| % Institutions | 5.35% |
Data last updated: 4/7/2026